Loading…
Based on limited metadata, the FDA issued a warning letter to GC Natural on July 13, 2018, regarding products classified outside the standard pharmaceutical, device, or dietary supplement categories. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing office is not specified in the metadata provided. To understand the regulatory concerns and required corrective actions, the complete warning letter would need to be reviewed.